Registration: DRKS00013027
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically relevant side effect of cancer treatment. According to a recent review, 68.1% of patients suffer from CIPN by the first month after completion of chemotherapy [1].
